Showing results (111-120 of 540) with videos related to
Sort By:
Pageof 54
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 1, 1996
Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphomaR M Giusti, E M Maloney, B Hanchard, et al.Proceedings of the National Academy of Sciences of the United States of America|April 11, 1992
Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriersZ N Berneman, R B Gartenhaus, M S Reitz, et al.The Journal of Infectious Diseases|March 1, 1996
Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patientsC Rattray, H D Strickler, C Escoffery, et al.Research Communications in Molecular Pathology and Pharmacology|June 1, 1997
Pharmacokinetics of adriamycin and adriamycinol after intravenous administration of adriamycin to rats with water-deprivation for 48 hoursH J Lee, M G LeeJournal of Clinical and Hospital Pharmacy|September 1, 1981
Absorption of isosorbide dinitrate by PVC infusion bags and administration setsM G Lee, V Fenton-MayJournal of Pharmaceutical Sciences|August 1, 1993
Influence of protein and calorie malnutrition on the pharmacokinetics and pharmacodynamics of bumetanide in ratsS H Kim, M G LeeBiopharmaceutics & Drug Disposition|December 18, 2001
Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effectsE J Kim, M G LeeThe Journal of Pharmacy and Pharmacology|August 28, 1998
Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in ratsK S Han, M G LeePageof 54